be complete and be optimal: how might bimekizumab impact psa clinical practice? | philippe carron
Published 2 years ago • 518 plays • Length 3:19Download video MP4
Download video MP3
Similar videos
-
6:27
the be complete and be optimal trials of bimekizumab in psa | joseph merola
-
0:40
adapt to evolving treatment guidelines with simman critical care
-
5:39
early treatment intensification for mcspc: optimising patient selection and treatment
-
0:40
remove the workflow challenges of mbir
-
4:36
q&a | how to sequence car t-cell therapy and bispecific antibodies in r/r mm
-
2:12:16
how to develop the perfect vmat plan for pelvic cases... on first attempt
-
59:16
better stream: the rezum procedure for the treatment of bph
-
1:07
dr. penson on treatment selection in metastatic hormone-sensitive prostate cancer
-
2:04
unmet need in bladder cancer
-
4:38
how do you select a pro?
-
2:02
8 steps to find a cure for a disease - bayer
-
2:00
for cancer patients, mutations matter.
-
59:54
bch lecture: breakthroughs in detecting and treating prostate cancer sept-22
-
9:16
bph diagnosis in 2023: guidelines at a glance
-
1:39
how do doctors decide on what treatment is suitable
-
0:54
neo-checkray: chemotherapy and sbrt with durvalumab and oleclumab in er /her2- breast cancer
-
1:51
how do you know you are getting the right diagnosis?
-
0:38
new findings could change the everyday treatment of patients with advanced prostate cancer
-
4:00
comprehensive care pathway, urology
-
1:14
how mpmri scans improve prostate cancer diagnosis
-
0:34
pembrolizumab plus enfortumab vedotin for bladder cancer